Wednesday, 18 Oct 2017

You are here

One-Third of Americans Took Opioids in 2015

 In the wake of the well-publicized "opioid epidemic", researchers report in the Annals of Internal Medicine (online July 31) that more than one third of U.S. adults were prescribed opioids in 2015 and that misuse remains a major problem. (Citation source http://buff.ly/2vkd8au)

Limited data on the prescription of opioids and their abuse are available despite the number of deaths from drug overdoses in the U.S. having quadrupled between 1999 and 2015. 

Using data from 51,200 adults collected in 2015 National Survey on Drug Use and Health (NSDUH), researchers estimate about 38 percent of U.S. adults (or 92 million people) were prescribed an opioid in 2015. 

Opioid use was lower between ages 18 and 49 years, and less in men or college graduates but greater in older, female or non-college graduates.

Overall 5% reported misusing opioids. This was higher in those taking prescription opioids (12.5%), and 16.7% reported a prescription opioid use disorder. Misuse was more common amongst the unemployed, low income, or those with behavioral health problems.

Compared to 2010 there appears to be a 20 percent decline in opioid use but many feel this is not a major reduction.

 

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

High Drug Discontinuations and Nonadherence in Fibromyalgia

Compliance and adherence was shown to be quite poor in fibromyalgia (FM) patients, with high rates of drug discontinuation and greater than 60% demonstrated low adherence.

Increasing Deaths and Breaking Bad with Fentanyl

Opioid overdose deaths quadrupled from 1999 to 2015 and accounted for 63% of drug overdose deaths in the United States in 2015. During 2010–2015, heroin overdose deaths quadrupled from 3,036 to 12,989, with heroin and illicitly manufactured fentanyl (IMF) as likely contributors to this trend. (additional citation https://buff.ly/2eHAjpn)

No Evidence to Support Use of Gabapentinoids in Low Back Pain

Management of chronic low back pain (CLBP) is often complex, requiring multiple modalities and meds to control pain. An analysis of studies shows that Gabapentinoids, including pregabalin and gabapentin, have little to no benefits but significant risk of adverse effects.  (Citation source https://buff.ly/2warMSU)

Marijuana Has Little Effect on Most Types of Pain

Cannabis has become a regulated product, and many states have made it available with the intent of treating a variety of medical disorders, including chronic pain. A metanalysis published in Annals of Internal Medicine has shown that while cannabis may help neuropathic pain, it is not proven to benefit other types of chronic pain.

FDA Requests Removal of OPANA-ER from the Market

The U.S. Food and Drug Administration has asked Endo International to withdraw Opana ER from the market, stating that benefits no longer outweigh its risks of this long-acting opioid.

A March 2017 advisory committee concluded that Opana ER, is not safe, and many have called for its removal.

Opana ER is twice as potent as oxycodone and has a high abuse potential when crushed and taken for a massive high effect by addicts.